TREATMENT OF AUTOIMMUNE HEMOLYTIC ANAEMIA WITH RITUXIMAB
<p>Background. Autoimmune haemolytic anaemia (AIHA) is characterised by the presence of autoantibodies directed against autologous erythrocytes. Depending on temperature at which they are active AIHA is classified as AIHA due to warm or cold-reacting antibodies. Glucocorticoids are the mainsta...
Main Author: | Uroš Mlakar |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2004-12-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2425 |
Similar Items
-
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
by: Irina Murakhovskaya
Published: (2020-12-01) -
Cold autoimmune haemolytic anaemia secondary to Epstein Barr virus infection presenting with peripheral gangrene; case report
by: Karunarathne Suneth, et al.
Published: (2012-04-01) -
Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome
by: Mohammad Mahdi Adib Sereshki, et al.
Published: (2019-04-01) -
Treatment of Autoimmune Haemolytic Anaemia with Hepatitis C Virus-A Real Challenge
by: A Basu, et al.
Published: (2016-10-01) -
Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis
by: Paul R.J. Ames, et al.
Published: (2020-06-01)